Sinovac Biotech Ltd (SVA) — Free Cash Flow Generation Index
Sinovac Biotech Ltd (SVA) has a Free Cash Flow Generation Index of 0.64x as of December 2023. Free cash flow of $93.26 Million represents 1% of operating cash flow ($146.01 Million). See Sinovac Biotech Ltd (SVA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinovac Biotech Ltd Free Cash Flow Generation Index (2007–2023)
Historical FCF Generation Index trend for Sinovac Biotech Ltd across 12 annual periods. Explore SVA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sinovac Biotech Ltd (2007–2023)
Year-by-year Free Cash Flow Generation Index for Sinovac Biotech Ltd. For the full company profile including market capitalisation, see SVA stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.39x | $-41.69 Million | $106.02 Million | $145.69 Million | ▼ -141.3% |
| 2021 | 0.95x | $14.63 Billion | $15.35 Billion | $719.98 Million | ▲ +29.9% |
| 2020 | 0.73x | $351.66 Million | $479.31 Million | $127.65 Million | ▲ +0.8% |
| 2019 | 0.73x | $28.45 Million | $39.07 Million | $10.63 Million | ▲ +148.2% |
| 2018 | 0.29x | $2.33 Million | $7.94 Million | $5.61 Million | ▼ -63.4% |
| 2017 | 0.80x | $47.84 Million | $59.76 Million | $11.91 Million | ▲ +409.9% |
| 2015 | -0.26x | $-1.09 Million | $4.21 Million | $5.30 Million | ▼ -425.2% |
| 2013 | 0.08x | $443.00K | $5.58 Million | $5.13 Million | ▲ +172.8% |
| 2011 | -0.11x | $-1.52 Million | $13.94 Million | $15.46 Million | ▼ -112.0% |
| 2009 | 0.91x | $44.09 Million | $48.41 Million | $4.32 Million | ▲ +46.6% |
| 2008 | 0.62x | $6.53 Million | $10.50 Million | $3.98 Million | ▲ +45.0% |
| 2007 | 0.43x | $1.85 Million | $4.32 Million | $2.47 Million | — |